Filters

Peter Itin, Karine Litherland, Armin Wolf, Francois Pognan, Joanna Ashton-Chess, Dirk J Schaefer, Reto Wettstein, Barbara Ling, Markus Walles, Hilmar Schiller, Olivier Kretz, Gian Camenisch, Barbara Bertschi, Kamal Kumar Balavenkatraman, Piet Swart, Nenad Manevski

Drug metabolism and disposition: the biological fate of chemicals 2015;43(1):126-39

Full Text

Abstract

Nicotinamide -Methyltransferase: An Emerging Protagonist in Cancer Macro(r)evolution.

Paul D Facey, Richard B Parsons

Biomolecules 2022;11(10):1418

Free Full Text

Abstract

Serum vitamin C and other biomarkers differ by genotype of phase 2 enzyme genes GSTM1 and GSTT1.

Gladys Block, Nishat Shaikh, Christopher D Jensen, Vitaly Volberg, Nina Holland

The American journal of clinical nutrition 2011;94(3):929-37

Free Full Text

Abstract

Mechanisms of acetaminophen-induced liver injury and its implications for therapeutic interventions.

Hongbo Hu, Shutao Yin, Yazhen Huo, Mingzhu Yan

Redox biology 2018;17():274-283

Free Full Text

Abstract

Pharmacogenetics of the nuclear hormone receptors: the missing link between environment and drug effects?

Elena De Mattia, Eva Dreussi, Erika Cecchin, Giuseppe Toffoli

Pharmacogenomics 2014;14(16):2035-54

Full Text

Abstract

One-week administration of hydroxytyrosol to humans does not activate Phase II enzymes.

Maria Isabel Espinosa, Viviana Loria Kohen, Emma Burgos-Ramos, Joao Tomé-Carneiro, Maria Carmen Crespo, Jesus Herranz, Francesco Visioli

Pharmacological research 2016;95-96():132-7

Full Text

Abstract

Results: 1 – 15 / 23

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Metabolic Detoxication, Phase II""[mesh_terms]

Role of phase II drug metabolizing enzymes in cancer chemoprevention.

Interindividual differences in phytochemical metabolism and disposition.

Guided Metabolic Detoxification Program Supports Phase II Detoxification Enzymes and Antioxidant Balance in Healthy Participants.

Effects of naringenin and its phase II metabolites on in vitro human macrophage gene expression.

Detoxification basics.

Intestinal phase-II metabolism of quercetin in HT29 cells, 3D human intestinal tissues and in healthy volunteers: a qualitative comparison using LC-IMS-MS and LC-HRMS.

Herbal bioactivation, molecular targets and the toxicity relevance.

Urinary excretion kinetics of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its phase I and phase II metabolites in humans following controlled MDMA administration.

Colonic catabolism of ellagitannins, ellagic acid, and raspberry anthocyanins: in vivo and in vitro studies.

Phase II metabolism in human skin: skin explants show full coverage for glucuronidation, sulfation, N-acetylation, catechol methylation, and glutathione conjugation.

Nicotinamide -Methyltransferase: An Emerging Protagonist in Cancer Macro(r)evolution.

Serum vitamin C and other biomarkers differ by genotype of phase 2 enzyme genes GSTM1 and GSTT1.

Mechanisms of acetaminophen-induced liver injury and its implications for therapeutic interventions.

Pharmacogenetics of the nuclear hormone receptors: the missing link between environment and drug effects?

One-week administration of hydroxytyrosol to humans does not activate Phase II enzymes.

Results for
""Metabolic Detoxication, Phase II""[mesh_terms]